(2022). Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer.
Chicago Style (17th ed.) CitationBaseline Extracellular Vesicle TGF-β Is a Predictive Biomarker for Response to Immune Checkpoint Inhibitors and Survival in Non–small Cell Lung Cancer. 2022.
MLA (8th ed.) CitationBaseline Extracellular Vesicle TGF-β Is a Predictive Biomarker for Response to Immune Checkpoint Inhibitors and Survival in Non–small Cell Lung Cancer. 2022.
Warning: These citations may not always be 100% accurate.